Before the Fleming Fund investment, Papua New Guinea had limited capacity for surveillance of antimicrobial resistance (AMR). Laboratory…
The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.
We support low- and middle-income countries to generate, share and use data to improve antimicrobial usage and encourage investment in antimicrobial resistance (AMR).
The Eastern Regional Hospital in Koforidua (ERHK), Ghana, is an antimicrobial resistance (AMR) surveillance site supported by the Fleming…
In a significant milestone for antimicrobial resistance (AMR) surveillance in Pakistan, the Fleming Fund Country Grant (FFCG), led by DAI,…
Studies & Reports
From Studies & Reports, Antibiotics are failing in many countries in Africa, new study reveals. , Date: 24/06/2025
The largest retrospective study on antibiotic resistance (AMR) in Africa highlights the need for major investments to enhance laboratory…
- 26
- Active Country Grants
- 20
- Active Regional Grants
- 321
- Supported surveillance sites
- 25
- Countries we work in (up to)
- 170
- National Action Plans developed with Fleming Fund support
- 155
- Countries have supplied data on use of antimicrobial medicines in animals to WOAH database
The threat of mortality, morbidity, and economic loss associated with antimicrobial resistance (AMR) poses a significant burden on…
Two landmark projects aimed at strengthening the Caribbean’s capacity to fight antimicrobial resistance (AMR) were launched on 5 May, at …
Studies & Reports
From Studies & Reports, WHO releases Global AMU data to guide progress against AMR , Date: 02/05/2025
A major driver of AMR is the inappropriate use of antimicrobials. This is a common issue in many resource-limited countries with poor…
Stories
From Stories, Transforming AMR surveillance in Nepal through data automation , Date: 30/04/2025
Antimicrobial resistance (AMR) data is vital for informing local interventions, enabling hospitals to improve infection control and…